AnimalBiome

Microbiome-based diagnostics and supplements for pets with chronic digestive disorders

AnimalBiome is active in the consumer bio space based in United States, founded in 2016.

Profile

AnimalBiome creates microbiome-based therapeutics to treat the more than nine million cats and dogs in the U.S. living with chronic digestive disorders. We have developed a process for creating a fecal microbiota transplant pill that is stable at room temperature and highly effective.

Its activity falls under consumer bio; the profile below is assembled from public directory data.

The business is associated with United States.

Directory data places it at the SOSV portfolio company stage.

Recorded headcount: 2-10 employees.

Website: animalbiome.com